Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...
After Judith Harding was diagnosed with multiple myeloma in 2009, she decided to retire, sold her condo, dropped out of her PhD program and moved nearer to her family, preparing to "live out my last ...
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life ...
Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord–Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After ...
Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma. Myeloma affects bone marrow ...
The main chemotherapy agent of Biodexa's MTX110, panobinostat, was initially used to treat multiple myeloma, received FDA approval in 2015. MTX110 combines a water-soluble form of panobinostat ...
Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit. It’s important for patients with ...
A promising new treatment for multiple myeloma, recently approved by the Food and Drug Administration, has been offered at UConn Health, the first in the United States. Dr. Swarup Kumar, who leads ...
My wife, Michelle, has used this diagnosis as a pillar of strength, doing all she can for her young boys and me and leading the best life she can, while along the way committing to raise funds and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback